Article

Cushing's disease in dogs and humans.

Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands.
Hormone Research (Impact Factor: 2.48). 02/2009; 71 Suppl 1:140-3. DOI: 10.1159/000178058
Source: PubMed

ABSTRACT BACKGROUND: Cushing's disease (CD) is a common endocrinological disorder in dogs with an estimated incidence of 1 to 2 cases/1,000 dogs/year. This is in contrast to humans in whom CD is rare. The clinical presentation of CD, however, is highly similar between dogs and humans, with characteristic signs, such as abdominal obesity, weight gain, fatigue, muscle atrophy and skin changes. Canine CD may therefore serve as an animal model for human CD, especially since therapeutic canine hypophysectomy can generate substantial amounts of primary corticotroph adenoma tissue for in vitro research purposes. In a recent study, we found that dopamine (DA) D(2) and somatostatin (SS) receptor subtypes are well expressed in canine corticotroph adenomas, but there are some distinct differences compared with the expression profile observed in human CD. These differences need to be considered when using canine CD as a model to evaluate the efficacy of novel DA/SS compounds for potential use in human CD. CASE REPORT: This case involves an 8-year-old female dog that developed signs of exercise intolerance, muscle weakness and polyuria/polydipsia due to an adrenocorticotropic hormone-secreting pituitary adenoma. The dog underwent curative transsphenoidal hypophysectomy and has remained in complete remission in the 3.5 years since surgery.

0 Bookmarks
 · 
96 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Subcellular molecular mechanisms underlying ACTH-secreting pituitary adenomas remain elusive. Genetic and acquired animal and cell models have provided insights into corticotroph cell tumorigenesis, including cell cycle abnormalities and aberrant glucocorticoid feedback mechanisms. Novel peptide therapies targeting somatostatin and/or dopamine (D2) receptors and emerging microRNA studies may shed light on additional cellular pathways that regulate tumoral corticotroph cell function. Studying human pituitary corticotroph tumor biology is challenging. The rarity of the disease, as well as the small tumor size and commonly encountered specimen contamination with adjacent “normal” pituitary tissue, all represent obstacles to studying disease mechanisms. Moreover, the lack of normal/ non-autopsy derived human pituitary tissue and the inability to separate pure populations of viable corticotroph cells in primary non-human pituitary cultures does not enable easy comparison between normal and abnormal corticotroph cells. Therefore, despite technological and biological advances improving our knowledge of Cushing’s disease, the pathophysiology of pituitary corticotroph adenomas remains unclear. This chapter focuses on accumulating knowledge, emphasizing recent progress in identifying molecular and genetic mechanisms contributing to the pathogenesis of Cushing’s disease. Key WordsCorticotroph adenoma-ACTH-Pituitary tumor-POMC gene-T-Pit
    09/2010: pages 31-40;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Both spondylosis and diffuse idiopathic skeletal hyperostosis (DISH) are prevalent in humans and are considered distinct entities. Nowadays, the term spondylosis is in the biomedical literature mostly used when also degenerative disc disease is present. In companion animals, many reports on spondylosis, often without intervertebral disc degeneration, are described. The nomenclature and the definitions of both spondylosis and DISH in the biomedical and veterinary literature should be more in line to facilitate comparison. DISH occurs in dogs but has not been described in cats yet. DISH and spondylosis can co-occur in dogs in one animal. Boxers may serve as translational disease models for the elucidation of the gene(s) involved in the (etio)pathogenesis of DISH or serve as a test population for newly developed treatment options.
    The Veterinary quarterly. 02/2013;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Pituitary surgery generates pituitary tissue for histology, immunohistochemistry, and molecular biological research. In the last decade, the pathogenesis of pituitary adenomas has been extensively studied in humans, and to a lesser degree in dogs, and tumor oncogenesis has been studied in knock-out mice, often by means of quantitative reversed-transcriptase PCR (RT-qPCR). A precondition of such analyses is that so-called reference genes are stably expressed regardless of changes in disease status or treatment. In this study, the expression of six frequently used reference genes, namely, tata box binding protein (tbp), tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (ywhaz), hydroxymethylbilane synthase (hmbs), beta-2-microglobulin (b2m), succinate dehydrogenase complex subunit A (sdha), and glyceraldehyde 3 phosphate dehydrogenase 1 (gapdh), was studied in pituitary tissue (normal and adenoma) from three species (humans, mice, and dogs). The stability of expression of these reference genes differed between species and between healthy and diseased tissue within one species. Quantitative analysis based on a single reference gene that is assumed to be stably expressed might lead to wrong conclusions. This cross-species analysis clearly emphasizes the need to evaluate the expression stability of reference genes as a standard and integral aspect of study design and data analysis, in order to improve the validity of the conclusions drawn on the basis of quantitative molecular analyses.
    Molecular Neurobiology 10/2013; · 5.47 Impact Factor

Full-text

View
4 Downloads
Available from
Jul 28, 2014